All Online

1 - 12 of 26 results

Refine

Active filters

Pulmonary Medicine
1 CME CREDIT

Review practice-changing articles from 2020! During this informative session on medical literature updates (excluding COVID-19), primary care physician, Dr. Charles Vega, will review the clinical implications of practice-changing literature that has been recently published. Topics for discussion will include: HPV vaccination, mammography, colorectal cancer screening, osteoporosis, coconut oil, milk and weight gain, mask efficacy, COPD exacerbations, medication-assisted treatment for opioid disorder and more! You don’t want to miss these important updates!


0.5 CME CREDIT

Twelve million individuals with COPD in the U.S. remain undiagnosed. Join Dr. Charles Vega as he provides practical, evidence-based guidance for diagnosing COPD in a primary care setting. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on August 18th 2020 and they are subject to change as new information is published.


0.5 CME CREDIT

Twelve million individuals with COPD in the U.S. remain undiagnosed. Join Dr. Charles Vega as he provides practical, evidence-based guidance for diagnosing COPD in a primary care setting. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on August 18th 2020 and they are subject to change as new information is published.


0.83 CME CREDIT

Meet your next patient: follow this case of a 23-year-old woman with shortness of breath from presentation to diagnosis, management, and monitoring to improve your care of patients with difficult-to-control asthma. Please note that any data, indications, and guidelines presented in this activity are current as of 6/18/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

Join pulmonologist Dr. Matthew Drake as he discusses the current 2020 GOLD guidelines for treatment of COPD. Using patient case examples, he will outline how to assess patients with COPD to determine the most appropriate evidence-based treatment. Discussion will include which patients will benefit most from inhaled corticosteroids and when to consider triple inhaled therapy with combination of long-acting beta-2-agonist, long acting muscarinic antagonist and inhaled corticosteroids. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 10/9/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

Acute Exacerbations of COPD: Challenges and Opportunities

0.50 CME/MOC
0.38 AANP | 0.19 Pharmacology

Join pulmonologist Dr. Chris Fanta as he discusses acute exacerbations and COPD. The podcast begins with a typical case presentation seen in primary care which highlights the experience of acute exacerbations of COPD. Next, Dr. Fanta discusses the impact of COPD on the lives of patients and, lastly, discusses how COPD is treatable and, to some extent, preventable in an outpatient setting. Please note that any data, indications, and guidelines presented in this activity are current as of the recording 9/1/2020 and they are subject to change as new information is published.


0.29 CME CREDIT

In this podcast, Dr. Matthew Drake, a pulmonary and critical care medicine specialist at Oregon Health & Science University, will answer questions regarding diagnosis, evaluation and management of severe asthma. He will review how to identify and evaluate patients with severe asthma, and will describe newer treatments available for patients with specific subtypes of severe asthma. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 5/29/2020 and they are subject to change as new information is published.


0.25 CME CREDIT

The Infectious Disease Society of America in conjunction with the American Thoracic Society have updated their guidelines on diagnosing and treating Community Acquired Pneumonia (CAP) in adults. Recommended changes from the 2007 guidelines include how to address the growing issue of antibiotic resistance. We will review this latest recommendation, focusing on the best approach for outpatient care.


0.25 CME CREDIT

COPD Exacerbations: Who Needs Antibiotics? - Frankly Speaking EP 145

Guest: Alan Ehrlich MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

Patients with COPD frequently have exacerbations, often triggered by an acute upper respiratory infection (URI). C-reactive protein (CRP) testing is a new way of assessing whether or not antibiotics are needed to treat.


0.25 CME CREDIT

Are E-Cigarettes Effective Tools for Smoking Cessation, or Are We Just Blowing Smoke? - Frankly Speaking EP 117

Guest: Jill Terrien PhD, ANP-BC & Susan Feeney, DNP, FNP Music Credit: Richard Onorato

0.25 CME

The FDA has not approved any ENDS product as an effective or safe smoking cessation tool. Earlier evidence did not indicate that ENDS were effective or sustainable. Most of these studies were done on earlier prototypes of e-cigarettes. A recent study from the UK found that newer generation ENDS were more successful than approved NRT products for smoking cessation. Join us as we discuss this new evidence and how it impacts strategies to assist with smoking cessation.


0.33 CME CREDIT

Join pulmonologist Emily Wan, MD as she answers the most pressing questions regarding the management of COPD. In this podcast, Dr. Wan will discuss topics such as when to step-up and step-down therapy, the role of eosinophil count in acute exacerbations, strategies for educating patients on correct inhaler technique (hint – don’t forget about the pharmacist!), how COVID-19 has impacted the management of COPD, and more.


0.25 CME CREDIT

This podcast will review updates to the clinical guidelines for the management of chronic obstructive pulmonary disease, tailored specifically to primary care. The discussion will include the diagnosis and basic management of COPD, when to consider escalating and deescalating treatment regimens, and when to consider expert referral.